Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects
Neuropsychiatric symptoms (NPS) are prevalent in mild cognitive impairment (MCI), but we do not know much about their role in progression to dementia. To investigate NPS and the risk of progression to probable Alzheimer's disease dementia (AD) among subjects with MCI. 96 MCI participants were f...
Saved in:
Published in | Journal of Alzheimer's disease Vol. 70; no. 1; p. 25 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
01.01.2019
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Neuropsychiatric symptoms (NPS) are prevalent in mild cognitive impairment (MCI), but we do not know much about their role in progression to dementia.
To investigate NPS and the risk of progression to probable Alzheimer's disease dementia (AD) among subjects with MCI.
96 MCI participants were followed for 4 years. Progression to probable AD was defined by the change of CDR total score from 0.5 to ≥1, reviewed by an expert consensus panel. NPS were determined using the Neuropsychiatric Inventory (NPI) 12-items. This study analyzed prognostic value of each NPI item and 5 sub-syndromes of NPS (apathy, psychosis, affective, hyperactivity, and vegetative) for prediction of progression to probable AD. A Cox proportional hazard model was used; hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated with time dependent variable to compare the incidence of progression considering presence/absence of any NPS or sub-syndromes throughout the study.
The presence of symptoms "agitation/aggression", "delusions", and "aberrant motor behavior" significantly increased the risk of probable AD (HR = 3.9; 95% CI = 1.9-8.2; HR = 13.9; 95% CI = 4.1-48.9; HR = 4.3; 95% CI = 1.7-10.3, respectively). The presence of sub-syndromes "psychosis" and "hyperactivity" were also predictors of progression (HR = 14.0; 95% CI = 4.4-44.5; HR = 2.0; 95% CI = 1.1-3.7, respectively). These results did not change after adjusting by potential confounders.
Presence of delusions, agitation/aggression, and aberrant motor behavior is predictor of progression to probable AD. |
---|---|
AbstractList | Neuropsychiatric symptoms (NPS) are prevalent in mild cognitive impairment (MCI), but we do not know much about their role in progression to dementia.
To investigate NPS and the risk of progression to probable Alzheimer's disease dementia (AD) among subjects with MCI.
96 MCI participants were followed for 4 years. Progression to probable AD was defined by the change of CDR total score from 0.5 to ≥1, reviewed by an expert consensus panel. NPS were determined using the Neuropsychiatric Inventory (NPI) 12-items. This study analyzed prognostic value of each NPI item and 5 sub-syndromes of NPS (apathy, psychosis, affective, hyperactivity, and vegetative) for prediction of progression to probable AD. A Cox proportional hazard model was used; hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated with time dependent variable to compare the incidence of progression considering presence/absence of any NPS or sub-syndromes throughout the study.
The presence of symptoms "agitation/aggression", "delusions", and "aberrant motor behavior" significantly increased the risk of probable AD (HR = 3.9; 95% CI = 1.9-8.2; HR = 13.9; 95% CI = 4.1-48.9; HR = 4.3; 95% CI = 1.7-10.3, respectively). The presence of sub-syndromes "psychosis" and "hyperactivity" were also predictors of progression (HR = 14.0; 95% CI = 4.4-44.5; HR = 2.0; 95% CI = 1.1-3.7, respectively). These results did not change after adjusting by potential confounders.
Presence of delusions, agitation/aggression, and aberrant motor behavior is predictor of progression to probable AD. |
Author | Soto, Maria Ousset, Pierre Jean de Mauleon, Adelaïde Kiyasova, Vera Dietlin, Simon Pueyo, Maria Delrieu, Julien Vellas, Bruno |
Author_xml | – sequence: 1 givenname: Simon surname: Dietlin fullname: Dietlin, Simon organization: Gerontopôle, INSERM U 1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, France – sequence: 2 givenname: Maria surname: Soto fullname: Soto, Maria organization: Gerontopôle, INSERM U 1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, France – sequence: 3 givenname: Vera surname: Kiyasova fullname: Kiyasova, Vera organization: Institut de Recherches Internationales Servier, Suresnes, France – sequence: 4 givenname: Maria surname: Pueyo fullname: Pueyo, Maria organization: Institut de Recherches Internationales Servier, Suresnes, France – sequence: 5 givenname: Adelaïde surname: de Mauleon fullname: de Mauleon, Adelaïde organization: Gerontopôle, INSERM U 1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, France – sequence: 6 givenname: Julien surname: Delrieu fullname: Delrieu, Julien organization: Gerontopôle, INSERM U 1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, France – sequence: 7 givenname: Pierre Jean surname: Ousset fullname: Ousset, Pierre Jean organization: Gerontopôle, INSERM U 1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, France – sequence: 8 givenname: Bruno surname: Vellas fullname: Vellas, Bruno organization: Gerontopôle, INSERM U 1027, Alzheimer's Disease Research and Clinical Center, Toulouse University Hospital, France |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31127783$$D View this record in MEDLINE/PubMed |
BookMark | eNo1jztPwzAYAC0Eog9Y-AHIG1PAsZs4GaOWR1F5iMJcOfbn1qW2g-0ihV8PEjDddroboUPnHSB0lpNLRhm7um9mWV4TQosDNMwrXmRVTaoBGsW4JYQwUvNjNGB5Tjmv2BB9PMI--C72cmNECkbiZW-75G3Ewin8YuI79ho_B78OEKPxDiePm93XBoyFcBHxzEQQEXBjvVvjB7NTeOrXziTzCXhuO2GCBZfwct9uQaZ4go602EU4_eMYvd1cv07vssXT7XzaLDLJqjxlgnJQZfHTWwPTUEzaqtZcc9ZKVmrJJKsl1bqsFSg5KUjZkpICVWWrJCit6Rid_3q7fWtBrbpgrAj96v-dfgPsdl2T |
CitedBy_id | crossref_primary_10_1038_s41398_024_02968_y crossref_primary_10_1177_08919887221093361 crossref_primary_10_1186_s13195_023_01255_0 crossref_primary_10_1590_1980_5764_dn_2020_0096 crossref_primary_10_1186_s12877_024_05203_x crossref_primary_10_1016_j_jagp_2021_12_014 crossref_primary_10_1016_j_neuint_2021_105250 crossref_primary_10_1186_s12877_023_04447_3 crossref_primary_10_1186_s12877_023_04580_z crossref_primary_10_3233_JAD_190828 crossref_primary_10_1590_1980_5764_dn_2024_0187 crossref_primary_10_1038_s44220_023_00191_0 crossref_primary_10_1097_WAD_0000000000000480 crossref_primary_10_2147_NDT_S454943 crossref_primary_10_3233_JAD_200604 crossref_primary_10_3233_JAD_230170 crossref_primary_10_1038_s41380_022_01459_0 crossref_primary_10_3233_JAD_220857 crossref_primary_10_1038_s41582_021_00597_3 crossref_primary_10_1111_jnc_15715 crossref_primary_10_3389_fnagi_2021_718949 crossref_primary_10_3233_JAD_215555 crossref_primary_10_1159_000507078 crossref_primary_10_1186_s13195_020_00604_7 crossref_primary_10_2174_1567205019666220805114528 crossref_primary_10_1177_17474930211006294 crossref_primary_10_1186_s13195_024_01386_y crossref_primary_10_1016_j_nbas_2022_100044 crossref_primary_10_1111_psyg_12697 crossref_primary_10_1007_s13311_022_01185_z crossref_primary_10_1002_alz_12519 crossref_primary_10_3233_JAD_240556 crossref_primary_10_1080_13854046_2023_2273574 crossref_primary_10_1038_s44220_023_00043_x crossref_primary_10_1016_j_jagp_2024_06_005 crossref_primary_10_3389_fneur_2024_1422681 crossref_primary_10_1002_dad2_12164 crossref_primary_10_2174_1871527322666230301111216 crossref_primary_10_1124_pharmrev_124_001117 crossref_primary_10_3233_JAD_210037 crossref_primary_10_1177_08919887221093353 crossref_primary_10_1186_s13195_024_01526_4 crossref_primary_10_1007_s11065_023_09608_0 |
ContentType | Journal Article |
DBID | NPM |
DOI | 10.3233/JAD-190025 |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
EISSN | 1875-8908 |
ExternalDocumentID | 31127783 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- 0R~ 0VX 29J 36B 4.4 53G 5GY AAFNC AAWTL ABDBF ABIVO ABJNI ABUBZ ABUJY ACGFS ACPQW ACPRK ACUHS ADZMO AELRD AENEX AFRAH AFRHK AGIAB AHDMH AIRSE AJNRN ALMA_UNASSIGNED_HOLDINGS CAG COF DU5 EAD EAP EBS EJD EMB EMK EMOBN ESX F5P HZ~ IL9 IOS MET MIO MV1 NGNOM NPM O9- P2P Q1R S70 SV3 TUS VUG |
ID | FETCH-LOGICAL-c381t-a27ed650979e3fe54b89f7f73bc36fc3c39c2ff69dedc4506b062e2d6bdcedff2 |
IngestDate | Thu Apr 03 07:05:57 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | dementia mild cognitive impairment Alzheimer’s disease neuropsychiatric symptoms |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c381t-a27ed650979e3fe54b89f7f73bc36fc3c39c2ff69dedc4506b062e2d6bdcedff2 |
PMID | 31127783 |
ParticipantIDs | pubmed_primary_31127783 |
PublicationCentury | 2000 |
PublicationDate | 2019-01-01 |
PublicationDateYYYYMMDD | 2019-01-01 |
PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Journal of Alzheimer's disease |
PublicationTitleAlternate | J Alzheimers Dis |
PublicationYear | 2019 |
SSID | ssj0003097 |
Score | 2.438837 |
Snippet | Neuropsychiatric symptoms (NPS) are prevalent in mild cognitive impairment (MCI), but we do not know much about their role in progression to dementia.
To... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 25 |
Title | Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31127783 |
Volume | 70 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swELbKJiFe0KYNGGyTHybxgDzSOInrx2oMMSYmRGHiDcXOWUSiTUdTpPbv2B-8s52kbQTT2EsU2UkU5ftyvjvfD0I-acBVN1IhiyAQLEp5l6lunLFAK7SIeGJSlx599iM5uYpOr-PrTuf3UtTStFSf9fzRvJL_QRXHEFebJfsMZJuH4gCeI754RITx-E8Yu8oaTbxyrg8Gs-G4LIa-7vJFFTV-bkOwfPkNq2n27-a3kLumKWJiq2_aDZqDvms6dJbfZSgi6oiibygr8nsXLoACxnpsJk8psysPbe36HOVQVn3hB_lwse8_KFwPJ5svlDerw_d8lk6KB6fT_oT7Zvx8CrPW1ZWzwuZHNc4K8AIW7SPWk0FvWQL71iErTKvEafyYlOeh9UIfn_aPGKozwepFiNB46PDmqEoK4dvk_H22VXG7nloja2h72Gaq1gNUre48kMKXubWvcbh4iQ2yXt_YMlGcqnL5imxWsNC-J8xr0oHRG_KrTRZak4UiWaglCy0MXSILLQva4Lo_oRVVqKMKtVShDVXogiq0pspbcnX89fLLCav6bTCNelvJ0lBAZisqCgncQBypnjTCCK40_rSaay51aEwiM8h0FAeJCpIQwixRmYbMmHCLvBgVI9gh1NjGj4FC256jxZ5yaWQsQaC0VyrSSfcd2fZf6Gbsi6rc1N9u98mZPbKxoNR78tLgXwwfUCUs1UeH0R_l_2Xy |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neuropsychiatric+Symptoms+and+Risk+of+Progression+to+Alzheimer%27s+Disease+Among+Mild+Cognitive+Impairment+Subjects&rft.jtitle=Journal+of+Alzheimer%27s+disease&rft.au=Dietlin%2C+Simon&rft.au=Soto%2C+Maria&rft.au=Kiyasova%2C+Vera&rft.au=Pueyo%2C+Maria&rft.date=2019-01-01&rft.eissn=1875-8908&rft.volume=70&rft.issue=1&rft.spage=25&rft_id=info:doi/10.3233%2FJAD-190025&rft_id=info%3Apmid%2F31127783&rft_id=info%3Apmid%2F31127783&rft.externalDocID=31127783 |